Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06938685 · ClinicalTrials.gov registry record · NA
Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers
A NA study of Diabetic Foot Ulcer, sponsored by NuScience Medical Biologics.
- Recruiting
- Registry status
- NA
- Development phase
- 132
- Enrollment target
- 5
- Study locations
NCT06938685 is a NA study of Diabetic Foot Ulcer that is actively recruiting participants, run by NuScience Medical Biologics. The registered enrollment target is 132 participants, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (48% lower). The trial reports 5 study locations across 3 states.
The verdict
NCT06938685, a NA study of Diabetic Foot Ulcer, is actively recruiting participants, sponsored by NuScience Medical Biologics.
- RECRUITING
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a randomized controlled crossover trial evaluating the efficacy of NeoThelium FT in conjunction with standard of care vs. standard of care alone in treating diabetic foot ulcers.
Conditions Studied
Interventions
- OTHER Standard of Care
- OTHER NeoThelium FT
Study Locations (5)
Louisiana
- MedCentris of Alexandria - Alexandria
- MedCentris of Monroe - Monroe
Mississippi
- MedCentris of Natchez - Natchez
- MedCentris of Picayune - Picayune
Pennsylvania
- Pace Foot and Ankle Center - Bryn Mawr
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2025-10-06 |
| Est. Completion | 2026-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06938685
The ClinicalTrials.gov registry entry for NCT06938685 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (48% lower). The listed sponsor is NuScience Medical Biologics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT06938685 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Louisiana, Mississippi, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06938685 about?
NCT06938685 is a clinical study titled "Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers". This is a randomized controlled crossover trial evaluating the efficacy of NeoThelium FT in conjunction with standard of care vs. standard of care alone in treating diabetic foot ulcers.
What is the current status of trial NCT06938685?
This trial is currently recruiting. It is a NA study. The enrollment target is 132 participants. The study started on 2025-10-06. Estimated completion is 2026-10-01.
What conditions does trial NCT06938685 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer.
What interventions are being tested in trial NCT06938685?
The interventions under investigation include: Standard of Care (OTHER), NeoThelium FT (OTHER).
Who is sponsoring clinical trial NCT06938685?
This trial is sponsored by NuScience Medical Biologics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06938685 being conducted?
This trial has 5 study locations across Louisiana, Mississippi, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.